Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
505–540
Headlines
5310
Sources here
17
Companies here
18
Current section United States Medical Devices news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

PLNT Investor Alert: Planet Fitness, Inc. Securities Class Action Notice - Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed a class action lawsuit against Planet Fitness, Inc. (NYSE: PLNT) on behalf of investors who purchased securities between November 6, 2025, and May 6, 2026. The lawsuit alleges that Planet Fitness made misleading statements regarding its marketing strategy …

PODD mentioned
Sharemaestro market context Price below Trend Line 52 weeks -56.7% · Next-week setup negative 41.7% PODD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

UFP Technologies Director Joseph John Hassett Files Corrected Beneficial Ownership Amendment

UFP Technologies Director Joseph John Hassett has filed an amended statement of beneficial ownership to correct an administrative error in a previous filing. The amendment updates his beneficial ownership from 2,425 to 2,602 shares of Common Stock. This correction relates to a transaction on …

UFPT mentioned
Sharemaestro market context Trend signal active 52 weeks +42.5% UFPT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

UFP Technologies (UFPT) director amends Form 4 to correct 2,602-share holding

UFP Technologies director Joseph John Hassett has filed an amended Form 4 to correct an administrative error in his previously reported share holdings. The amendment clarifies that his correct beneficial ownership of Common Stock, $.01 Par Value, following a reported transaction was 2,602 shares, …

UFPT main company
Sharemaestro market context Trend signal active 52 weeks +42.5% UFPT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lumexa Imaging earnings on deck: Profitability in focus

Lumexa Imaging Holdings Corp. is set to report Q2 earnings, with investors focused on the company's ability to maintain profitability and execute its growth strategy. Analysts expect an EPS of $0.20, an 11% sequential improvement, and all eight analysts rate the stock a Strong …

LMRI main company
Sharemaestro market context Price above Trend Line 36 weeks -35.1% · Next-week setup negative 28.5% LMRI stored weekly price path from 12 Dec 2025 to 14 Aug 2026

PODD Shareholder Alert: Insulet Corporation Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Levi & Korsinsky, LLP has issued a shareholder alert regarding a securities class action lawsuit against Insulet Corporation (NASDAQ: PODD). The lawsuit alleges that former EVP and COO Eric Benjamin made false statements about Omnipod product safety while selling $3.7 million in company stock. …

PODD main company
Sharemaestro market context Price below Trend Line 52 weeks -56.7% · Next-week setup negative 41.7% PODD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ENvue Medical secures $50M equity financing facility By Investing.com

ENvue Medical, Inc. has announced a securities purchase agreement with an institutional investor for an equity financing facility of up to $50 million, subject to stockholder approval. The medical technology company plans to use the capital to advance its technology platform, accelerate the adoption …

FEED main company
Sharemaestro market context Price below Trend Line 52 weeks -91.9% · Next-week setup negative 31.4% FEED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Every 2 Seconds, Someone in the U.S. Needs Blood as Abbott Drive Returns

Abbott (NYSE: ABT) and the Big Ten Conference have relaunched their "We Give Blood" nationwide competition to address a critical blood supply crisis in the U.S. All 18 Big Ten universities will compete to generate the most blood donations, with Abbott awarding $1 million …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.8% · Next-week setup positive 55.5% ABT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.8% · Next-week setup positive 55.5% ABT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)

This article summarizes recent analyst ratings for three healthcare companies: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX), and Agios Pharma (AGIO). Bank of America Securities maintained a Hold rating on GEHC, while Truist Financial analysts maintained Buy ratings on both Vertex Pharmaceuticals and …

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quanterix (QTRX) Earnings Shake Up The Story As Fair Value Still Sits Higher

Quanterix (QTRX) recently released its Q2 2026 earnings report, showing higher revenue but a wider net loss and a lowered full-year revenue outlook, alongside the appointment of a new Chief Commercial Officer. Despite these mixed results, the stock saw a brief rebound, suggesting investors …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IceCure Medical (Nasdaq: ICCM) lifts H1 revenue 45% but burns cash

IceCure Medical Ltd. (ICCM) reported a 45% increase in H1 2026 revenue to $1.818 million, driven by higher system and disposable probe sales. Despite this growth, the company experienced a deepened net loss of $8.775 million and negative operating cash flow, leading management to …

ICCM main company
Sharemaestro market context Price below Trend Line 52 weeks -88.6% · Next-week setup negative 38.7% ICCM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ENvue Medical secures up to $50M equity facility to fund growth plans

* ENvue Medical (FEED [https://seekingalpha.com/symbol/FEED]) said on Wednesday that it entered into a securities purchase agreement [https://seekingalpha.com/pr/20616538-envue-medical-secures-equity-financing-facility-of-up-to-50-million-to-support-commercial] with an institutional investor for an equity facility of up to $50M, subject to stockholder approval. * The funding will support the expansion of its ENvue feeding …

FEED main company
Sharemaestro market context Price below Trend Line 52 weeks -91.9% · Next-week setup negative 31.4% FEED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up

Tandem Diabetes Care (TNDM) reported a Q2 2026 loss of 31 cents per share, which was narrower than expected, though worldwide revenues of $254.6 million missed consensus estimates. Despite the revenue miss, the company's shares rose 19.1% after the announcement, driven by increased pump …

TNDM main company
Sharemaestro market context Price above Trend Line 52 weeks +90.4% TNDM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year

IceCure Medical Ltd. announced strong financial results for the first half of 2026, reporting a 45% year-over-year revenue growth to $1.8 million, driven by increased sales of its ProSense® systems and disposable probes. The company expanded its U.S. commercial footprint by 70% and ended …

ICCM main company
Sharemaestro market context Price below Trend Line 52 weeks -88.6% · Next-week setup negative 38.7% ICCM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ENVUE Medical (FEED) adds $50M equity facility and boosts $59M Series H rights

ENVUE Medical (FEED) has secured a new committed equity facility of up to $50 million with an institutional investor, allowing the company to sell common shares at its discretion, with 40% of net proceeds earmarked for Series X Preferred Stock redemption. Additionally, the company …

FEED main company
Sharemaestro market context Price below Trend Line 52 weeks -91.9% · Next-week setup negative 31.4% FEED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ENvue Medical Secures $50 Million Equity Facility; Expands Series H Investment Rights to $59 Million

ENvue Medical has secured a $50 million committed equity facility with an institutional investor and increased its Series H preferred financing Additional Investment Rights to $59 million. The equity facility allows ENvue to sell common shares at 90% of the lowest VWAP over three …

FEED main company
Sharemaestro market context Price below Trend Line 52 weeks -91.9% · Next-week setup negative 31.4% FEED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ENvue Medical Eyes AI, Automation, Acquisitions With Up to $50M

ENvue Medical (NASDAQ: FEED) has secured an equity financing facility of up to $50 million, pending stockholder approval, to boost its financial flexibility. The capital is intended to advance its next-generation medical technology platform, including AI and automation technologies, and to fund strategic acquisitions. …

FEED main company
Sharemaestro market context Price below Trend Line 52 weeks -91.9% · Next-week setup negative 31.4% FEED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions

ENvue Medical, Inc. announced a securities purchase agreement with an institutional investor for an equity facility of up to $50 million, pending stockholder approval. This financing aims to enhance ENvue's financial flexibility, advance its next-generation technology, and support strategic acquisitions and business development. The …

FEED main company
Sharemaestro market context Price below Trend Line 52 weeks -91.9% · Next-week setup negative 31.4% FEED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Oppenheimer Sees $500 for Intuitive Surgical as Rivals Stall

This article first appeared on GuruFocus. Intuitive Surgical (NASDAQ:ISRG) rose 0.90% premarket after Oppenheimer upgraded the robotic surgery company to Outperform from Perform with a $500 price target. The firm's case rests less on Intuitive than on its competitors: workflow integration problems for Johnson …

MDT mentioned
Sharemaestro market context Price above Trend Line 52 weeks -4.1% MDT stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Kenneth Samet Bought 94% More Shares In AdaptHealth

Independent Director Kenneth Samet recently purchased US$150k worth of AdaptHealth (NASDAQ:AHCO) shares at US$6.38 each, increasing his holding by 94%. This insider buying activity, along with other purchases totaling US$511k over the last year, suggests a bullish sentiment despite the company's recent loss. Insiders …

AHCO main company
Sharemaestro market context Price below Trend Line 52 weeks -39.5% AHCO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Northside Capital Management LLC Increases Position in GE HealthCare Technologies Inc. $GEHC

Northside Capital Management LLC has increased its stake in GE HealthCare Technologies Inc. by 26.5% during the second quarter, bringing its total holdings to 241,923 shares valued at $15.5 million. This move comes as GE HealthCare reported strong quarterly earnings of $1.13 per share, …

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.50

Treace Medical Concepts (NASDAQ:TMCI) recently released its Q2 earnings, with revenues exceeding expectations at US$45m and statutory losses coming in smaller than anticipated at US$0.24 per share. Following the report, analysts increased their price target for TMCI to US$5.50, reflecting a moderate uplift in …

TMCI main company
Sharemaestro market context Trend signal active 52 weeks -37.8% TMCI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wedge Capital Management L L P NC Boosts Holdings in GE HealthCare Technologies Inc. $GEHC

Wedge Capital Management L L P NC significantly increased its stake in GE HealthCare Technologies Inc. by 27.8% in the second quarter, bringing its total holdings to 461,283 shares valued at $29.5 million. This move comes as GE HealthCare reported strong quarterly earnings, exceeding …

GEHC main company
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Hub Group, Inc. (HUBG), Insulet Corporation (PODD), and Photronics, Inc. (PLAB) Announced by Holzer & Holzer, LLC

Holzer & Holzer, LLC has announced lead plaintiff deadlines for shareholder class action lawsuits against Hub Group, Inc. (HUBG), Insulet Corporation (PODD), and Photronics, Inc. (PLAB). The lawsuits allege false or misleading statements regarding financial results, revenue recognition, internal controls, manufacturing controls, and product …

PODD main company
Sharemaestro market context Price below Trend Line 52 weeks -56.7% · Next-week setup negative 41.7% PODD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

2 Growth Stocks with Explosive Upside and 1 Facing Headwinds

2 Growth Stocks with Explosive Upside and 1 Facing Headwinds Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. …

IRTC mentioned
Sharemaestro market context Price above Trend Line 52 weeks -25.2% IRTC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AI-Enabled Imaging Modalities Market Report: Evaluating AI Software Integration, FDA Approvals, and Competitive Strategies of GE HealthCare, Canon, Siemens, and Philips

Company Logo Accelerating clinical adoption highlighted by GE HealthCare's latest FDA clearance for AI-guided radiation planning, Canon Medical's AI deep-learning CT launch, and strong 2026 order books across Siemens Healthineers and Philips is transforming diagnostic workflows globally. This study delivers an in-depth competitive analysis, …

GEHC mentioned PHG mentioned
Sharemaestro market context Price above Trend Line 52 weeks -1.9% GEHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CODX Q2'26 Earnings: EPS estimate is (3.00) USD

Co-Diagnostics, Inc. (CODX) is scheduled to release its Q2'26 earnings on August 13th, after market close, with an anticipated announcement time of 4:01 PM ET (8:01 PM UTC). Analysts estimate revenue for the quarter to be 132.58 thousand USD and earnings per share (EPS) …

CODX main company
Sharemaestro market context Price below Trend Line 52 weeks -85.4% · Next-week setup negative 40.9% CODX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Northside Capital Management LLC Purchases 49,189 Shares of Boston Scientific Corporation $BSX

Northside Capital Management LLC significantly increased its stake in Boston Scientific Corporation by 44.2% in the second quarter, bringing its total holdings to 160,366 shares valued at $6.84 million. The medical equipment provider has a consensus "Moderate Buy" rating from analysts and recently reported …

BSX main company
Sharemaestro market context Price below Trend Line 52 weeks -52.2% · Next-week setup negative 40.9% BSX stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott Laboratories $ABT Shares Sold by West Branch Capital LLC

West Branch Capital LLC significantly reduced its stake in Abbott Laboratories (NYSE:ABT) by 83.5% in the second quarter, selling 13,061 shares and retaining 2,576 shares worth $234,000. Despite this sell-off, institutional investors collectively own 75.18% of Abbott’s stock. Abbott reported strong Q2 earnings of …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.8% · Next-week setup positive 55.5% ABT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context